循環器内科 Twitter アカウントlanguage English

英文原著論文　Original Papers in English


緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2024 年 】（IF: 2022 年）

  1. Teramoto K, Nochioka K, Sakata Y, Kato ET, Nishimura K, Shimokawa H, Yasuda S, the SUPPORT Trial Investigators. Growth differentiation factor-15 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum- Int J Cardiol. (in press) (IF=3.5)

  2. Suzuki H, Inoue T, Terui Y, Takeuchi K, Susukita K, Arai M, Sato H, Satoh T, Yamamoto S, Yaoita N, Tatebe S, Hayashi H, Nochioka K, Takahama H, Yasuda S. Evaluating hemodynamic changes: vericiguat in patients with heart failure with reduced ejection fraction. ESC Heart Failure (in press) (IF=3.8)

  3. Fukumoto Y, Tada T, Suzuki H, Nishimoto Y, Moriuchi K, Arikawa T, Adachi H, Momomura S, Seino Y, Yasumura Y, Yokoyama H, Hiasa G, Hidaka T, Nohara S, Okayama H, Tsutsui H, Kasai T, Takata Y, Enomoto M, Saigusa Y, Yamamoto K, Kinugawa K, Kihara Y. Chronic effects of adaptive servo-ventilation therapy on mortality and the urgent rehospitalization rate in patients experiencing recurrent admissions for HF: a multicenter, prospective, observational study (SAVIOR-L). Circulation Journal (in press) (IF=3.3)

  4. Shindo T, Eguchi K, Monma Y, Kanai H, Yasuda S, Shimokawa H. Optimal treatment conditions of the low-intensity pulsed ultrasound therapy for the treatment of Alzheimer’s disease -Applications from mice to humans- J Med Ultrasonics. (in press) (IF=1.8)

  5. Yamanaka S, Nochioka K, Hayashi H, Shiroto T, Takahashi J, Miyata S, Yasuda S, Shimokawa H. Age-stratified profiles and outcomes of patients with heart failure with preserved ejection fraction. ESC Heart Failure (in press) (IF=3.8)

  6. Nakano M, Yasuda S, Hasebe Y, Nochioka K, Fukuda K, Takahashi J, Shimokawa H. Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation. Int J Cardiol Heart & Vasculature. (in press) (IF=2.9)

  7. Yamamoto N, Noda T, Nakano N, Ito T, Sato H, Hayashi H, Chiba T, Hasebe Y, Ueda N, Kamakura T, Ishibashi K, Miyata S, Kusano K, Yasuda S. Clinical Utility of QRS Duration Normalized to Left Ventricular Volume for Predicting Cardiac Resynchronization Therapy Efficacy in Patients with "Mid-Range" QRS Duration Heart Rhythm 2024 Feb 15:S1547-5271(24)00190-5.(Online ahead of print) DOI: 10.1016/j.hrthm.2024.02.019. (IF=5.5)

  8. Teramoto K, Nochioka K, Sakata Y, Nishimura K, Shimokawa H, Yasuda S, the SUPPORT Trial Investigators. Prognostic significance of growth differentiation factor-15 across age in chronic heart failure. ESC Heart Failure (in press) (IF=3.8)

  9. Ouchi D, Mori S, Arakawa M, Shindo T, Shimokawa H, Yasuda S, Kanai H. Optimizing irradiation conditions for low-intensity pulsed ultrasound to upregulate endothelial nitric oxide synthase. J Med Ultrasonics 51:39-48,2024. (IF=1.8)

  10. Fujihashi T, Nochioka K, Yasuda S, Sakata Y, Hayashi H, Shiroto T, Takahashi J, Miyata S, Shimokawa H. Underuse of heart failure medications and poor long-term prognosis in chronic heart failure patients with polypharmacy -A report from the CHART-2 Study- Int J Cardiol Heart & Vasculature. (in press) (IF=2.9)

【 2023 年 】（IF: 2022 年）

  1. Okubo N, Sugawara S, Fujiwara T, Sakatsume K, Doman T, Yamashita M, Goto K, Tateishi M, Suzuki M, Shirakawa R, Eura Y, Kokame K, Hayakawa M, Matsumoto M, Kawate Y, Miura M, Takiguchi H, Soga Y, Shirai S, Ando K, Arai Y, Nakayoshi T, Fukumoto Y, Takahama H, Yasuda S, Tamura T, Watanabe S, Kimura T, Yaoita N, Shimokawa H, Saiki Y, Kaikita K, Tsujita K, Yoshii S, Nakase H, Fujimaki S, Horiuchi H. VWF:RCo/VWF: Ag for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis. Thromb Haemost. (in press) (IF=6.7)

  2. Kubota H, Masato Tsutsui M, Kuniyoshi K, Yamashita H, Shimokawa H, Sugahara K, Kakinohana M. Alleviated cerebral infarction in male mice lacking all nitric oxide synthase isoforms after middle cerebral artery occlusion. J Anesthesia. DOI: 10.1007/s00540-023-03271-8 (IF=2.8)

  3. Takeuchi M, Suzuki H, Miyata S, Ebihara S, Yasuda S. Angina, a preoperative clinical sign for the development of delirium after transcatheter aortic valve implantation Geriatrics & Gerontology International (in press) (IF=3.3)

  4. Nochioka K, Shiroto T, Hayashi H, Inoue T, Oyama K, Susukita K, Takahama H, Takahashi J, Shimokawa H, Yasuda S. Long-term prognostic significance of history of cancer and atrial fibrillation in coronary artery disease. Int J Cardiol Heart & Vasculature. (in press) (IF=2.9)

  5. Satoh T, Yaoita N, Nochioka K, Tatebe S, Hayashi H, Yamamoto S, Sato H, Takahama H, Suzuki H, Terui Y, Yamada K, Yamada Y, Inoue T, Aoki T, Satoh K, Sugimura K, Miyata S, Yasuda S. Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases. ESC Heart Fail. 2023 Sep 29. doi:10.1002/ehf2.14515. Online ahead of print. PMID: 37775984 (IF=3.8)

  6. Nochioka K, Kato S, Pileggi G, Horii K, Shiroto T, Shimokawa H, Yasuda S. Serial assessment of cardiothoracic ratio as a predictor of progression from stage B to stage C heart failure in asymptomatic patients with cardiac diseases. Int J Cardiol Heart & Vasculature 2023 Sep 17;48:101273. doi: 10.1016/j.ijcha.2023.101273. (IF=2.9)

  7. Terui Y, Suzuki H, Chikata A, Hanaki Y, Komatsu Y, Ota H, Fujishima F, Umezawa R, Ouchi K, Sato H, Satoh T, Miyamichi-Yamamoto S, Yaoita N, Hayashi H, Nochioka K, Takahama H, Nogami A, Saiki Y, Yasuda S. Intractable ventricular tachycardia prior to overt cardiac tumor mass of metastatic cardiac rhabdomyosarcoma (spindle-cell type) Internal Medicine. 2023 (in press) (IF=1.2)

  8. Shimizu W, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H. Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: a subanalysis of the EXPAND study. Int J Cardiol. (in press) (IF=3.5)

  9. Tatebe S, Yasuda S, Konno R, Sakata Y, Sugimura K, Satoh K, Shiroto T, Miyata S, Adachi O, Kimura M, Mizuno Y, Enomoto J, Tateno S, Nakajima H, Oyama K, Saiki Y, Shimokawa H. Clinical and sociodemographic factors associated with health-related quality of life in patients with adult congenital heart disease: A nationwide cross-sectional multicenter study. Circ J. Advance Publication DOI:10.1253/circj.CJ-23-0383 (IF=3.3)

  10. Kamiya K, Takei M, Nagai T, Miyoshi T, Ito H, Fukumoto Y, Obara H, Kakuma T, Sakuma I, Daida H, Iimuro S, Shimokawa H, Kimura T, Nagai R, Anzai T, the REAL-CAD study investigators. Association between non-lipid residual risk factors and cardiovascular events in patients with stable coronary artery disease treated with pitavastatin: An observation from the REAL-CAD Study. J Atheroscler Thromb. (in press)(IF=4.4)

  11. Mitsutake Y, Ishii J, Fukumoto Y, Ito S, Kashiwabara K, Uemura K, Matsuyama Y, Sugiyama Y, Ozaki Y, Iimuro S, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Hokimoto S, Miyauchi K, Daida H, Shimokawa H, Saito Y, Kimura T, Matsuzaki M, Nagai R. PDifferential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease. Int J Cardiol. 2023 Jun 22;131138. doi: 10.1016/j.ijcard.2023.131138. (Online ahead of print) (IF=3.5)

  12. Higuma T, Akashi YJ, Fukumoto Y, Obara H, Kakuma T, Asaumi Y, Yasuda S, Sakuma I, Daida H, Shimokawa H, Kimura T, Iimuro S, Nagai R. Residual coronary risk factors associated with long-term clinical outcomes in patients with coronary artery disease treated with high- versus low-dose statin therapy: REAL-CAD sub-study. Circ J. (in press) (IF=3.3)

  13. Shindo T, Ito K, Ogata T, Kurosawa R, Eguchi K, Kagaya Y, Hanawa K, Hasebe Y, Nishimiya K, Shiroto T, Takahashi J, Okumura Y, Noguchi T, Ozaki Y, Daida H, Hagiwara N, Masuyama T, Chikamori T, Fukumoto Y, Tsujita K, Kanai H, Yasuda S, Shimokawa H. A randomized, double-blind, placebo-controlled pilot trial of low-intensity pulsed ultrasound therapy for refractory angina pectoris. PLOS ONE 2023 Jun 23;18(6):e0287714. doi: 10.1371/journal.pone.0287714. (eCollection 2023) (IF=3.7)

  14. Nakamura M, Tamaru S, Hirooka S, Hirayama A, Tsuji A, Hirata M, Munemasa M, Nakagawa I, Toshima M, Shimokawa H, Nishimura Y, Ogura T, Yamamoto T, Satokawa H, Obayashi T, Yamada N; AKAFUJI Study Investigators. Efficacy and safety of warfarin for the treatment of venous thromboembolism: a multicenter prospective observational cohort study in Japan (AKAFUJI Study). Circ J. (in press) (IF=3.3)

  15. Morinaga J, Kashiwabara K, Torigoe D, Okadome Y, Aizawa K, Uemura K, Kurashima A, Matsunaga E, Fukami H, Horiguchi H, Sato M, Sugizaki T, Miyata K, Kadomatsu T, Mukoyama M, Miyauchi K, Hokimoto S, Fukumoto Y, Hiro T, Hibi K, Nakagawa Y, Sakuma I, Ozaki Y, Iwata H, Iimuro S, Daida H, Shimokawa H, Kimura T, Matsuzaki M, Saito Y, Matsuyama Y, Nagai R, Oike Y. Plasma ANGPTL8 levels and risk for secondary cardiovascular events in Japanese patients with stable coronary artery disease receiving statin therapy. Arterioscler Thromb Vasc Biol. 2023 Jun 1. doi: 10.1161/ATVBAHA.122.318880. (Online ahead of print) (IF=8.7)

  16. Ohyama-Tamagake A, Kaneko K, Itami R, Nakano M, Namioka Y, Izumi R, Sato H, Suzuki H, Takeda A, Okazaki Y, Yatsuka Y, Abe T, Murayama K, Sugeno N, Misu T and Aoki M. Adult-onset Leigh syndrome with a m.9176 T＞C mutation manifested as reversible cerebral vasoconstriction syndrome. Internal Medicine 2022 Dec 21. doi: 10.2169/internalmedicine.0773-22. (Online ahead of print) (IF=1.2)

  17. Takahama H, Nishimura K, Ahsan B, Hamatani Y, Makino Y, Nakagawa S, Irie Y, Moriuchi K, Amano M, Okada A, Kitai T, Amaki M, Kanzaki H, Noguchi T, Kusano K, Akao M, Yasuda S, Izumi C. Clinical application of artificial intelligence algorithm for prediction of one-year mortality in heart failure patients. Heart and Vessels 2023 Jun;38(6):785-792. doi: 10.1007/s00380-023-02237-w. (Epub 2023 Feb 20) (IF=1.5)

  18. Nakagawa S, Takahama H, Hoshino K, Yanagi Y, Irie Y, Moriuchi K, Amano M, Okada A, Amaki M, Kanzaki H, Kusano K, Noguchi T, Yasuda S, Izumi C. Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation. J Cardiol. 2022 Dec 21;S0914-5087(22)00325-2. doi: 10.1016/j.jjcc.2022.12.008. (Online ahead of print) (IF=2.5)

  19. Nakano K, Nochioka K, Yasuda S, Tamori D, Shiroto T, Sato Y, Takaya E, Miyata S, Kawakami E, Ishikawa T, Ueda T, Shimokawa H. Machine learning approach to stratify complex heterogeneity of chronic heart failure: A report from the CHART-2 Study. ESC Heart Fail. 10:1597–1604,2023. (IF=3.8)

  20. Kimura S, Kawamorita N, Ishizuka Y, Satake Y, Sato T, Izumi H, Shimokawa H, Ito A. Low-energy shock wave therapy ameliorates ischemic-induced overactive bladder in a rat model. Sci Rep. 2022;12:21960. DOI: 10.1038/s41598-022-26292 (IF=4.6)

  21. Fukui K, Takahashi J, Hao K, Honda S, Nishihara K, Kojima S, Takegami M, Sakata Y, Itoh T, Watanabe T, Takayama M, Sumiyoshi T, Kimura K, Yasuda S; on behalf of the JAMIR Investigators. Disparity of Performance Measure by Door-to-Balloon Time between Rural and Urban Area for Management of Patients with ST-Segment Elevation Myocardial Infarction -Insights from the Nationwide Japan Acute Myocardial Infarction Registry- Circ J 2023 Apr 25;87(5):648-656. doi: 10.1253/circj.CJ-22-0454. (Epub 2022 Dec 2) (IF=3.3)

  22. Terui Y, Sugimura K, Ota H, Tada H, Nochioka K, Sato H, Katsuta Y, Fujiwara J, Harada-Shoji N, Sato-Tadano A, Morita Y, Sun W, Higuchi S, Tatebe S, Fukui S, Miyamichi-Yamamoto S, Suzuki H, Yaoita N, Kikuchi N, Sakota M, Miyata S, Sakata Y, Ishida T, Takase K, Yasuda S, Shimokawa H. Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients. Int J Cardiol. 2023;371:472-479. (IF=3.5)

  23. Nakata T, Shindo T, Ito K, Eguchi K, Monma Y, Ichijo S, Ryoke R, Satoh W, Kumasaka K, Satoh H, Kurosawa R, Satoh K, Kawashima R, Miura M, Kanai H, Yasuda S, Shimokawa H. Beneficial effects of low-intensity pulsed ultrasound therapy on right ventricular dysfunction in animal models. JACC: Basic Trans Sci. 8(3):283–297,2023. DOI: 10.1016/j.jacbts.2022.08.010 (IF=9.7)